Quality Improvement in Neurology

Quality improvement in neurology: AAN Parkinson disease quality measures.

BACKGROUND Measuring the quality of health care is a fundamental step toward improving health care and is increasingly used in pay-for-performance initiatives and maintenance of certification requirements. Measure development to date has focused on primary care and common conditions such as diabetes; thus, the number of measures that apply to neurologic care is limited. The American Academy of ...

Quality improvement in neurology: Distal symmetric polyneuropathy quality measures.

Peripheral neuropathy is a common neurologic disorder, affecting 2% to 8% of the population in population-based studies with confirmation by neurologist examination. These prevalence numbers are remarkably stable across developed countries. In 1999, 8.6% of Medicare beneficiaries had neuropathy as a primary or secondary diagnosis, and the cost of treatment was estimated at $3.5 billion (Consume...

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

All clinicians believe they provide quality care, yet most clinicians do not directly measure quality parameters in their practice to provide verifiable health care outcomes. Quality measures related to a chronic disease provide reportable and repeatable measures that can either document performance of quality care or identify gaps in care for future action/improvement. Disease-specific quality...

Quality improvement in neurology: muscular dystrophy quality measures.

Quality improvement in neurology: Essential Tremor Quality Measurement Set.

Essential tremor (ET) is one of the most common movement disorders in the world, with prevalence rates in the general population ranging from 0.4% to 4.6%. The incidence of ET increases with age, with the average age at onset in mid-to-late 40s. ET is estimated to affect as many as 7 to 10 million Americans. Clinically, ET is characterized by bilateral, symmetric, postural tremor in hands and f...